Abstract
A privileged structure has been identified within the 1,300-member diversified library by rational selection of the compounds to be tested prior to the screening towards enzymatic β-secretase (BACE-1) assay. The identified hexahydrobenzothiazole privileged structure has been optimised and a preliminary structureactivity study has been performed.
Keywords: Diversified chemical library, screening, privileged structure, β-secretase (BACE-1), Alzheimer's disease, hexahydrobenzothiazole
Letters in Drug Design & Discovery
Title: Identification of Privileged Scaffolds from a Diversified Chemical Library forβ-Secretase Inhibition
Volume: 2 Issue: 8
Author(s): Nicolas Pietrancosta, Gilles Quelever, Cedrik Garino, Younes Laras, Stephane Burlet and Jean-Louis Kraus
Affiliation:
Keywords: Diversified chemical library, screening, privileged structure, β-secretase (BACE-1), Alzheimer's disease, hexahydrobenzothiazole
Abstract: A privileged structure has been identified within the 1,300-member diversified library by rational selection of the compounds to be tested prior to the screening towards enzymatic β-secretase (BACE-1) assay. The identified hexahydrobenzothiazole privileged structure has been optimised and a preliminary structureactivity study has been performed.
Export Options
About this article
Cite this article as:
Pietrancosta Nicolas, Quelever Gilles, Garino Cedrik, Laras Younes, Burlet Stephane and Kraus Jean-Louis, Identification of Privileged Scaffolds from a Diversified Chemical Library forβ-Secretase Inhibition, Letters in Drug Design & Discovery 2005; 2 (8) . https://dx.doi.org/10.2174/157018005774717352
DOI https://dx.doi.org/10.2174/157018005774717352 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Cannabis on the Adolescent Brain
Current Pharmaceutical Design Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
Current Respiratory Medicine Reviews Dimensional Assessment of Hypochondriacal Fears and Beliefs
Current Psychiatry Reviews Botulinum Toxin: A Successful Therapeutic Protein
Current Medicinal Chemistry COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Neural Receptors Associated with Depression: A Systematic Review of the Past 10 Years
CNS & Neurological Disorders - Drug Targets Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors
Current Topics in Medicinal Chemistry The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease
Current Medicinal Chemistry Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches
CNS & Neurological Disorders - Drug Targets Endoplasmic Reticulum Stress, Diabetes Mellitus, and Tissue Injury
Current Protein & Peptide Science Editorial [Hot Topic: The Medicinal Chemistry of Ubiquitin-Proteasome Pathway (UPP) and Its Relevance in Drug Discovery (Guest Editor: Yongqiang Zhu)]
Current Topics in Medicinal Chemistry Activin and TGF-β Effects on Brain Development and Neural Stem Cells
CNS & Neurological Disorders - Drug Targets Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Current Cancer Drug Targets Approaches to Target Profiling of Natural Products
Current Medicinal Chemistry Mechanisms of Action of Antiepileptic Drugs
Current Topics in Medicinal Chemistry A Focus on Microfluidics and Nanotechnology Approaches for the Ultra Sensitive Detection of MicroRNA
MicroRNA GHB in Biological Specimens: Which Cut-off Levels Should be Taken into Consideration in Forensic Toxicological Investigation?
Recent Patents on Biotechnology Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design Selenium and Neurological Diseases: Focus on Peripheral Pain and TRP Channels
Current Neuropharmacology Strategies of Functional Foods Promote Sleep in Human Being
Current Signal Transduction Therapy